The company is going to submit data to US FDA and European authorities for approval in a few months time, says Kiran Mazumdar Shaw, CMD, Biocon.
first published: Jun 6, 2016 10:20 am
A collection of the most-viewed Moneycontrol videos.

The Lawyer Renting in a 120-year-old building in South Mumbai | The Tenant

Nifty On Track To End Week Above 25,500 As Bank & Metal Stocks Lead Rebound| Closing Bell Live

Can Nifty Stage A Friday Fightback After Hitting 3-Week Low? Pine Labs IPO Opens | Opening Bell Live

Nifty Stays Below 25,600 Amid Expiry-Led Volatility; Grasim, Hindalco In Focus| Closing Bell Live
You are already a Moneycontrol Pro user.


